EMEA-001502-PIP01-13
Submitted by Anonymous (not verified) on 9 March 2026 - 15:36
EMEA-001502-PIP01-13
EMEA-001722-PIP01-14-M02
Submitted by Anonymous (not verified) on 9 March 2026 - 15:34
EMEA-001722-PIP01-14-M02
Record of data processing activity relating to Security Access Control System
Submitted by Anonymous (not verified) on 9 March 2026 - 15:30
Record of data processing activity relating to Security Access Control System
PSUSA/00001499/202502
Submitted by Anonymous (not verified) on 9 March 2026 - 15:00
PSUSA/00001499/202502
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 26, Status: Authorised
Submitted by Anonymous (not verified) on 9 March 2026 - 14:42
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Cayston, aztreonam, Date of authorisation: 21/09/2009, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 9 March 2026 - 14:32
Human medicines European public assessment report (EPAR): Cayston, aztreonam, Date of authorisation: 21/09/2009, Revision: 22, Status: Authorised
EMEA-003550-PIP01-23
Submitted by Anonymous (not verified) on 9 March 2026 - 13:53
EMEA-003550-PIP01-23
Agenda of the PRAC meeting 9-12 March 2026
Submitted by Anonymous (not verified) on 9 March 2026 - 13:50
Agenda of the PRAC meeting 9-12 March 2026
EMEA-003502-PIP02-24
Submitted by Anonymous (not verified) on 9 March 2026 - 13:47
EMEA-003502-PIP02-24
PRAC recommendations on safety signals
Submitted by Anonymous (not verified) on 9 March 2026 - 13:46
PRAC recommendations on safety signals